Yuan et al. reported that activation of NF-κB signaling pathway leads to increased lung inflammation, alveolar damage, and airway remodeling, which is consistent with the findings of this study and further confirms that SREBP2 has a proinflammatory effect in asthma [34]. Here, NFKB1 is linked to asthma.